CMS Switzerland has promoted Yoann Lambert (pictured left) and Maxence Carron (pictured right) to partner, effective 1 January 2026. Both professionals are based in Geneva and members of the firm’s litigation department, with Lambert specialising in
Niederer Kraft Frey (NKF) advised Tertianum Group — a privately operated service provider specialising in senior living, housing, and care — in connection with the amendment of its existing financing documentation required to enable the financing of
Digital media company DAAily platforms completed the sale of Architonic, a globally active design inspiration platform for architects and designers, to Sandow Companies. Baker McKenzie Switzerland — together with lawyers from Baker McKenzie Deutschland — advised the
CMS advised Bruker on the acquisition of an additional 60% ownership stake in Tofwerk, a Switzerland-based company, specialised in ultra-fast time-of-flight (TOF) mass spectrometry technology for small molecule applied markets. Pursuant to the deal, Bruker
Wenger Vieli advised Hoerbiger, a globally active technology group specialising in performance-defining components for several industries, in connection with the company’s acquisition of Karlsruhe-based PI, a high-precision motion and positioning solutions specialist. Pursuant to
Welcome to Signed, Sealed, Weekend, our weekly newsletter recap. Check out the news of the week: · SIX-listed Santhera Pharmaceuticals has signed an exclusive licensing agreement with biopharma company Nxera Pharma for the development, manufacturing and
Baker McKenzie Switzerland advised Swiss Finance & Property Group, as the Zurich-based company acquired a real estate portfolio of seventeen properties across Switzerland for the SF Retail Properties Fund. The transaction comes after a capital
Homburger advised 21Shares on the completion of a merger by absorption, pursuant to which FalconX, acquired 21Shares’ ultimate parent company. The transaction was completed in November 2025. Following the merger, 21Shares continues to operate as an
SIX-listed Santhera Pharmaceuticals has signed an exclusive licensing agreement with biopharma company Nxera Pharma for the development, manufacturing and commercialisation across Japan, South Korea, Australia and New Zealand of Agamree, a prescription medicine used to
Effective 1 January 2026, Borel & Barbey promoted Viviana Cibelli (pictured) to counsel. The profile Viviana Cibelli supports private and institutional clients across all areas of business law, with a particular focus to banking and finance
